CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
9140
Phase 1 mab active
Quick answer
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine for HER2 Negative Breast Carcinoma is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- HER2 Negative Breast Carcinoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active